ÂÜÀòÉÙÅ®

ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause The program includes the latest in research in chronic myeloid leukemia, including basic, translational and clinical research with an emphasis on open discussion among participants.

ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy

Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause 

Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Oliver Hantschel, Vignir Helgason, Sin Tiong Ong, Jerry Radich, Delphine Réa

Advisory Committee: J. Apperley, S. Branford, C. Gambacorti-Passerini, F. Guilhot, R. Hehlmann, P. Laneuville, F-X. Mahon, D. Perrotti, G. Saglio, C. Schiffer, S. Soverini, P. Valent, R. Van Etten

The program includes the latest in research in chronic myeloid leukemia, including basic, translational and clinical research with an emphasis on open discussion among participants. There are also scientific workshops to discuss the latest technologies of value in CML research, and clinical symposia with focus on topics of interest to the CML community. There are special lectures on topics of general interest to the CML community from lead experts in their field. The program is designed to encourage discussion and collaboration among participants, presenters and attendees.

Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Hematology CME system.

 

Posters and Brief Oral Communications:

Registered participants are invited to submit their Biology and Clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.

Call for abstracts: deadline May 22nd, 2025

The meeting will be of interest to:

- Junior and senior biologists and clinicians (MD, PhD, MD-PhD)

- Residents and biologists still in-training

- Physicians and other healthcare providers managing patients with CML

- Researchers with interest in hematologic malignancies and myeloproliferative neoplasms in general, and CML in particular

The program will include:

- Plenary Sessions

- Workshops for Non-Clinical Scientists

- Panel Discussions

- Simultaneous Meet the Expert Sessions

- Mentored Poster Walks

- Controversial Debates

- Ample Time for in-depth discussion

To register please follow the link:

For questions please email: [email protected]